RecruitingPhase 2NCT06386315

Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

MC230808 Reduced Dose Hypofractionated Radiotherapy (3Gy x 3 Fractions) for Indolent Non-Hodgkin Lymphoma (POSEIDON): A Multisite Phase 2 Randomized Trial


Sponsor

Mayo Clinic

Enrollment

112 participants

Start Date

May 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This phase II trial compares the safety, side effects and effectiveness of reduced dose radiation therapy to standard of care dose radiation in treating patients with indolent non-Hodgkin lymphoma. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Standard of care radiation treatment for indolent non-Hodgkin lymphoma is usually delivered in 12 treatments. Studies have shown indolent lymphoma to be sensitive to radiation treatment, however, larger doses have higher rates of toxicities. A reduced radiation dose may be safe, tolerable and/or effective compared to standard of care radiation dose in treating patients with indolent non-Hodgkin lymphoma.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a lower dose of radiation therapy works just as well as the standard dose for treating indolent (slow-growing) non-Hodgkin lymphoma, a type of blood cancer. A lower dose could mean fewer side effects while still effectively shrinking tumors. **You may be eligible if...** - You are 18 or older - You have been diagnosed with follicular lymphoma (grades 1, 2, or 3A), marginal zone lymphoma, or follicle center lymphoma - Your cancer can be at any stage — newly diagnosed, relapsed, or not responding to prior treatment - You are well enough to function reasonably well day-to-day (ECOG score 3 or less) **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have T-cell lymphoma - You are being treated for small/chronic lymphocytic lymphoma - You have grade 3B follicular lymphoma Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREComputed Tomography

Undergo CT or PET/CT

PROCEDUREEndoscopic Procedure

Undergo endoscopy

RADIATIONInvolved-site Radiation Therapy (3 Fractions)

Undergo ISRT in 3 fractions

RADIATIONInvolved-site Radiation Therapy (12 Fractions)

Undergo ISRT in 12 fractions

PROCEDUREPositron Emission Tomography

Undergo PET/CT

OTHERQuestionnaire Administration

Ancillary studies


Locations(7)

Mayo Clinic in Arizona

Scottsdale, Arizona, United States

Mayo Clinic in Florida

Jacksonville, Florida, United States

Mayo Clinic Health System in Albert Lea

Albert Lea, Minnesota, United States

Mayo Clinic Health System - Mankato

Mankato, Minnesota, United States

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Mayo Clinic Health System-Eau Claire Clinic

Eau Claire, Wisconsin, United States

Mayo Clinic Health System-Franciscan Healthcare

La Crosse, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06386315


Related Trials